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1  |  BACKGROUND
Ictal hypoxaemia (IH) is a major cause for concern due to its im-
portance in the life- threatening consequences of seizures. IH is a 
feature often seen in both focal and generalized seizures.1 Oxygen 
saturations <90% are reported during 20%– 30% of all seizures, with 
severe IH defined as an oxygen saturation below 85%.1,2 Severe IH in-
creases the risk of recurrent desaturation, resulting in longer seizures 
and a higher risk of sudden unexpected death in epilepsy (SUDEP).1,2 
Seizure- induced cardiorespiratory dysfunction has been recog-
nized as a significant risk factor in SUDEP pathophysiology.2 This 
is considered instrumental in the damage and dysfunction to the 
cortical and subcortical areas responsible for breathing regulation, 
resulting in seizure- induced central apnoea.1,2 Consequently, com-
promise in oxygen and carbon dioxide exchange may occur, resulting 
in hypoxaemia and hypercapnia.2 These changes, alongside a variety 
of other factors, can influence SUDEP occurrence.3
At present, the National Institute of Health and Care Excellence 
(NICE) recommends high flow oxygen use in hospital management of 
seizures; however, no reference source is provided.4 Contradicting 
this guidance, research has shown IH to be a mechanism of seizure 
termination, meaning oxygen administration may prolong seizures.5 
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Background: Ictal hypoxaemia is a feature seen in epileptic seizures, characterized by 
low oxygen saturations, increasing seizure prolongation risk and possibly contributing 
to sudden unexpected death in epilepsy (SUDEP). High flow oxygen is recommended 
in the management of seizures by UK’s National Institute of Health and Care excel-
lence (NICE); however, the evidence supporting this recommendation is unclear.
Aims: To identify the efficacy of oxygen in the seizure treatment.
Method: A scoping review was conducted using PRISMA- ScR guidance. PsycINFO, 
EMBASE and MEDLINE were searched along with the references section of identified 
literature. Articles were critically appraised for study, patient, seizure, oxygen ther-
apy and outcome characteristics, summarized and quality- assessed using Sackett's 
criteria.
Results: Literature search identified 623 articles of which five met the pre- criteria for 
full review. One animal study demonstrated favourable effects of oxygen adminis-
tration. Three human studies also reported favourable effects of oxygen administra-
tion, while one reported outcomes that were not statistically significant. Study design 
concerns in all identified literature confounded the ability to assess efficacy. All five 
publications were assigned Sackett's score of 2b.
Conclusion: There is a significant lack of evidence to support the efficacy of oxygen 
administration in epileptic seizures. Future research is needed.
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It also remains unclear whether peri- ictal oxygen administration is 
effective in treating the underlying central and obstructive apnoeic 
aetiology of IH.
1.1  |  Aim
The study looks to determine the nature and quality of evidence of 
oxygen therapy in the treatment of IH in seizures.
1.2  |  Methodology
A review was conducted using the Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses Extension for Scoping 
Reviews (PRISMA- ScR) as guidance (Supporting Information).6 A 
literature search of PsycINFO, EMBASE, and MEDLINE was com-
pleted to identify articles focussed on oxygen therapy in seizure 
management in human and animal models. The literature screening 
process is shown in Figure 1. The search methodology is provided in 
Appendix 1. Identification of relevant articles, followed by abstract 
screening and suitability assessment, was undertaken independently 
by two authors under supervision from the third author. The refer-
ences section of identified literature was searched for additional 
papers. No date range was used with the latest search executed in 
10/2020. Included articles were written in English, and all involved 
the use of oxygen therapy in the treatment of seizures in human and 
animal populations. No exclusions were made relating to other as-
pects of study design to capture the breadth of literature available. 
Each selected paper's provenance, study design, participant profile, 
seizure characteristics, oxygen therapy details, findings, identified 
bias and limitations was captured. Critical appraisal of each paper's 
quality was conducted using Sackett's criteria.7 No ethics were 
needed as this was a review not a human study.
2  |  RESULTS
The search yielded 623 articles of which 618 were excluded. Five pa-
pers were included in the analysis: four involving human participants 
and one based on animal models.
Detailed appraisal of each study is provided in Table 1.
Each study achieved Sackett's score of 2b. The animal and three 
human studies demonstrated favourable outcomes. One human 
study demonstrated no significant difference between participants 
who did or not receive oxygen administration.
2.1  |  Human models
A prospective cohort study investigated whether early adminis-
tration of oxygen improved postictal hypoxaemia in 76 patients 
(107 seizures).8 The oxygen saturation (SpO2) evolution during sei-
zures and postictal period was measured. The SpO2 nadir, its delay 
with respect to the end of generalized convulsive seizures (GCS) and 
occurrence of different severities of hypoxaemia were also assessed. 
Postictal hypoxaemia without early administration of oxygen lasted 
29.9 s longer on average (p = .035). Early oxygen administration 
caused a SpO2 nadir 9.1% higher than those without early adminis-
tration (p = .001), with a delay 6.4 s shorter with respect to the end 
of seizure (p < .001). These results demonstrate postictal hypoxae-
mia was shorter and less severe in those who received early oxygen 
administration.
A retrospective cohort study investigated the impact of peri- 
ictal nurse interventions on postictal generalized electroencepha-
lography suppression (PGES) in 150 GCS in 109 patients.9 One group 
(n = 29) received ictal oxygen administration, while another (n = 119) 
did not. Differences in seizure variables between groups were not 
statistically significant, demonstrating that oxygen administration 
was not linked to changes in seizure activity.
A multicentre prospective cohort study investigated the effect 
of early oxygen administration on the presence of PGES in 69 pa-
tients (99 GCS).10 The study concluded that PGES was more likely 
to be present in those who did not receive early oxygen administra-
tion in univariate and multivariate analysis (p < .001). The study also 
showed that early oxygen administration is protective against the 
development of PGES.
A retrospective cohort study was performed investigating the 
impact of peri- ictal interventions on respiratory dysfunction, PGES 
and postictal immobility.11 The study involved 39 patients (105 GCS) 
that were placed in two groups who either received (INT) or did not 
receive (NOINT) peri- ictal interventions. Duration of hypoxaemia 
was shorter in the INT group compared with NOINT when interven-
tion occurred prior to onset of hypoxaemia (p = .0014). Earlier in-
tervention was also associated with shorter duration of hypoxaemia F I G U R E  1  The literature screening process
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(p < .0001) and shorter PGES duration (p = .0012). The difference in 
entire seizure duration and individual seizure variables between the 
INT and NOINT groups was not statistically significant. The results 
showed that peri- ictal intervention following GCS is associated with 
reduced duration of respiratory dysfunction and PGES but had no 
effect on seizure duration and variables.
2.2  |  Animal model
A non- randomized controlled trial using various strains of audiogenic- 
seizure (AGS) susceptible mice (n = 279) was conducted.12 This study 
assessed the effect of oxygenation on incidence, severity and rate 
of fatality of AGS. Mice were placed in either a pure oxygen cham-
ber at the time of AGS or in an air chamber as a control and com-
pared against each other. Oxygenation resulted in zero AGS deaths, 
whereas most mice in air chambers died following AGS due to res-
piratory arrest. Further testing suggested that oxygenation had no 
long or short- term protective effect on fatality, incidence or severity 
of AGS (p < .01).
3  |  DISCUSSION
A small sample size was used in four identified human studies, re-
ducing their statistical power.8- 11 As a result, the outcomes of oxy-
gen therapy may not be representative of its efficacy in the general 
population. All studies included high levels of heterogeneity within 
their study samples. Factors including age of epilepsy onset, seizure 
type, disease duration, medication and demographics may have in-
troduced bias. In the animal model, variation in mouse strains may 
have confounded the results due to genetic variability in predis-
position to AGS and its potential influence on oxygen efficacy and 
mortality.12 The mechanism of AGS in mice and SUDEP in humans 
may share commonalities, but neither mechanism nor pathophysiol-
ogy is well understood meaning results cannot be directly applied to 
human participants.
Further bias may have been introduced in studies which with-
drew epileptic medication to induce seizure activity.8,9 Antiepileptic 
drug withdrawal can increase occurrence of certain seizure 
types.13 These may have a different aetiology of ictal hypoxaemia 
and therefore impact the efficacy of oxygen therapy. Future re-
search must aim to homogenize study methods in this regard.
Two studies reported outcomes retrospectively.9,11 This in-
herently predisposes research to selection bias and relies on pre- 
existing data to create relevant exposures and outcomes measures.
A significant limitation in three of the studies was the adminis-
tration of multiple interventions alongside oxygen.9- 11 This prevents 
the ability to conclude whether outcomes are solely due to oxygen 
therapy. In two studies, oxygen saturations and respiratory moni-
toring data were either discarded from use or performed at the dis-
cretion of the nursing staff, detracting from the richness of data and 
introducing the potential for information bias.9,10
The type of equipment used to administer oxygen was poorly 
documented, and where described variation between studies ex-
isted.8- 11 One human study commented on saturation sensor de-
tachment occurring in 76 seizures, with an association observed 
between detachment rate and oximetry sensor type (p < .05).8 
This demonstrates the need for consensus on the most appropri-
ate method of oxygen delivery and saturation equipment to use in 
future research. In all studies, the percentage of oxygen and rate 
of delivery were not discussed, impeding the ability to replicate 
findings.
3.1  |  Limitations
Despite a robust attempt to capture all relevant literature, some 
articles may have been missed due to language barriers, lack of 
access and lack of detailed information to draw valuable conclu-
sions. Search terms used may not have extracted all the relevant 
literature. Furthermore, the method of reporting outcomes was 
not always consistent for each study, complicating direct compari-
son. These factors have limited the potential breadth of literature 
available for this review, but are unlikely to have compromised its 
findings.
4  |  CONCLUSION
This review highlights a lack of evidence to support oxygen ad-
ministration during epileptic seizures. The evidence available is 
limited and suggests mixed outcomes. The study design of iden-
tified literature, heterogeneity among participants, lack of detail 
about oxygen administration, lack of respiratory data record-
ing, limited sample sizes and question over the most appropri-
ate respiratory monitoring hardware to use provide challenges 
to relying on the evidence. Crucially, human studies often did 
not investigate administration versus non- administration of oxy-
gen. They usually assessed early/late administration of oxygen 
in combination with other interventions. Future research should 
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Rheims et al. 2019
Demographics:
Total number of 
participants (n 
= 73)
Total number of 
seizures analysed 
(n = 107)












15.7 y/o mean, 10.7 years SD
Duration:
18.4 y/o mean, 11.5 years SD
Type of Seizures Observed:
GCS
45% GCS type 1
23% GCS type 2
32% GCS type 3
(Alexandre V, Mercedes B, Valton L, et al. 
Risk factors of postictal generalized 
EEG suppression in GCS. Neurology 
2015;85:1598– 1603.)
Raw Data Monitored During Seizures:
EEG, video, pulse oximetry and EKG
Method of seizure recording:
Long- term scalp EEG recordings
Diagnosis of Epilepsy:
International League Against Epilepsy 
Classification
Patients split into two groups: those who received early 
administration of O2 and those who did not receive 
early administration of O2
Early administration of O2 defined as receiving oxygen 
with nasal cannulae or mask during the seizure or 
within the first 5 s after seizure termination
Late administration of O2 defined as receiving oxygen 
with nasal cannulae or mask greater than 5 s after 
seizure termination
Transient hypoxaemia defined as SpO2 < 90% during at 
least 5 s
Moderate and severe hypoxaemia defined as SpO2 ≤80% 
and ≤70% respectively.
Details of oxygen therapy unclear. % of oxygen delivered 
unclear.
Improvement measures:
Evolution of SpO2 during the course of seizures and postictal period was 
assessed. Three minutes preceding the seizure, during the seizure and up to 
10 min after end of GCS.
Primary outcome
The duration of postictal hypoxaemia after GCS termination
Secondary outcomes
1. Nadir of SpO2 and its delay with respect to end of GCS
2. Occurrence and duration of moderate hypoxaemia (<80% SpO2) and severe 
hypoxaemia (<70% SpO2)
Significant p value = <.05
Outcomes:
O2 administered early in 42 seizures
O2 not administered early in 65 seizures
Early recovery of SpO2 ≥ 90% associated with early administration of O2 (p = 
.004)
Primary
GCS Without early administration of O2
Mean duration of postictal hypoxaemia— 71.1 s
GCS With early administration of O2
Mean duration of postictal hypoxaemia— 41.2 s
Comparison between GCS with and without early administration of O2 (p- value)
Mean duration of postictal hypoxaemia— 0.035
Secondary
GCS Without early administration of O2
SpO2 nadir— 69.6%
Delay between end of seizure and SpO2 nadir— 16.1 s
GCS With early administration of O2
SpO2 nadir— 78.7%
Delay between end of seizure and SpO2 nadir— 9.7 s
Comparison between GCS with and without early administration of O2 (p- value)
SpO2 Nadir— 0.001
Delay between end of seizure and SpO2 nadir— <0.001
Rate of GCS with severe hypoxaemia (SpO2 < 70%) dropped from 40% to 21% 
when O2 given early (p = .046)
Rate of GCS with moderate hypoxaemia (SpO2 < 80%) dropped from 69% to 
43% when O2 given early (p = .007)
No significant results related to duration of moderate or severe hypoxaemia in 
either group.
Other outcomes:
Evolution of SpO2 after GCS termination was associated with localization of 
epileptogenic zone, with slower recovery to SpO2 ≥ 90% in temporal lobe 
seizures
Early recovery of SpO2 ≥ 90% was associated with absence of postictal 
generalized EEG suppression.
Of 166 GCS in 114 patients with 
valid SpO2 measurements, 
only 107 GCS in 73 
patients could be used due 
to technical limitations 
(movement artefact on trace, 
removal of pulse oximeter, 
transient loss of signals 
and sensor repositioning) 
of using equipment pulse 
oximetry equipment which 
would have confounded 
results
Antiepileptic drug withdrawal 
may have been performed 
during recordings to promote 
occurrence of seizures (?may 
have confounded results as 
not an organic seizure?)
Unclear % O2 given to each 
patient
Oxygen mask or nasal cannulae 
delivery given to each 
patient meaning different 
oxygen deliveries
Different lobes of epileptic 
seizures may confound 
results as certain lobes may 
induce more debilitating 
seizures which worsen SpO2 
evolution
Limited sample size
Nasal airflow and abdominal 
respiratory excursions 
not recorded limiting 
interpretation of origins of 
respiratory apnoea
Sackett's score = 2b
Mean duration of postictal 
hypoxaemia significantly reduced 
with early O2 administration
SpO2 nadir significantly less severe 
with early O2 administration
Delay between end of seizure and 
SpO2 nadir significantly reduced 
with early O2 administration
Rate of transient loss of SpO2 
signal and sensor disconnection 
were associated with type of 
oximetry sensor (lower rates with 
disposable flexiform sensors than 
finger clip sensor or reusable soft 
sensor
Future research must identify the 
best type of pulse oximetry to use 
in GCS analysis of hypoxaemia
Localization of epileptogenic zone 
could be done in 71 patients only
Must be determined whether or not 
the therapeutic effect of oxygen 
administration might be increased 
through optimization of oxygen 
delivery protocol
Only specific seizure types (focal with 
bilateral tonic– clonic evolution) 
included in this study so scope in 
future studies to examine other 
epilepsy types
Question remains “Is O2 therapy 
efficacy altered by mechanism 
of hypoxaemia (different when 
triggered by central apnoea or 
obstructive apnoea)
Commentary on these articles 
suggests that providing the 
patient a suction machine 
and education on proper GCS 
intervention may serve better 
than O2 delivery, but this would 
need to be given further research 
(Kotagel p., 2019)
(Continues)
    |  5SMITH et al.
TA B L E  1  Critical appraisal and summary of identified literature














Rheims et al. 2019
Demographics:
Total number of 
participants (n 
= 73)
Total number of 
seizures analysed 
(n = 107)












15.7 y/o mean, 10.7 years SD
Duration:
18.4 y/o mean, 11.5 years SD
Type of Seizures Observed:
GCS
45% GCS type 1
23% GCS type 2
32% GCS type 3
(Alexandre V, Mercedes B, Valton L, et al. 
Risk factors of postictal generalized 
EEG suppression in GCS. Neurology 
2015;85:1598– 1603.)
Raw Data Monitored During Seizures:
EEG, video, pulse oximetry and EKG
Method of seizure recording:
Long- term scalp EEG recordings
Diagnosis of Epilepsy:
International League Against Epilepsy 
Classification
Patients split into two groups: those who received early 
administration of O2 and those who did not receive 
early administration of O2
Early administration of O2 defined as receiving oxygen 
with nasal cannulae or mask during the seizure or 
within the first 5 s after seizure termination
Late administration of O2 defined as receiving oxygen 
with nasal cannulae or mask greater than 5 s after 
seizure termination
Transient hypoxaemia defined as SpO2 < 90% during at 
least 5 s
Moderate and severe hypoxaemia defined as SpO2 ≤80% 
and ≤70% respectively.
Details of oxygen therapy unclear. % of oxygen delivered 
unclear.
Improvement measures:
Evolution of SpO2 during the course of seizures and postictal period was 
assessed. Three minutes preceding the seizure, during the seizure and up to 
10 min after end of GCS.
Primary outcome
The duration of postictal hypoxaemia after GCS termination
Secondary outcomes
1. Nadir of SpO2 and its delay with respect to end of GCS
2. Occurrence and duration of moderate hypoxaemia (<80% SpO2) and severe 
hypoxaemia (<70% SpO2)
Significant p value = <.05
Outcomes:
O2 administered early in 42 seizures
O2 not administered early in 65 seizures
Early recovery of SpO2 ≥ 90% associated with early administration of O2 (p = 
.004)
Primary
GCS Without early administration of O2
Mean duration of postictal hypoxaemia— 71.1 s
GCS With early administration of O2
Mean duration of postictal hypoxaemia— 41.2 s
Comparison between GCS with and without early administration of O2 (p- value)
Mean duration of postictal hypoxaemia— 0.035
Secondary
GCS Without early administration of O2
SpO2 nadir— 69.6%
Delay between end of seizure and SpO2 nadir— 16.1 s
GCS With early administration of O2
SpO2 nadir— 78.7%
Delay between end of seizure and SpO2 nadir— 9.7 s
Comparison between GCS with and without early administration of O2 (p- value)
SpO2 Nadir— 0.001
Delay between end of seizure and SpO2 nadir— <0.001
Rate of GCS with severe hypoxaemia (SpO2 < 70%) dropped from 40% to 21% 
when O2 given early (p = .046)
Rate of GCS with moderate hypoxaemia (SpO2 < 80%) dropped from 69% to 
43% when O2 given early (p = .007)
No significant results related to duration of moderate or severe hypoxaemia in 
either group.
Other outcomes:
Evolution of SpO2 after GCS termination was associated with localization of 
epileptogenic zone, with slower recovery to SpO2 ≥ 90% in temporal lobe 
seizures
Early recovery of SpO2 ≥ 90% was associated with absence of postictal 
generalized EEG suppression.
Of 166 GCS in 114 patients with 
valid SpO2 measurements, 
only 107 GCS in 73 
patients could be used due 
to technical limitations 
(movement artefact on trace, 
removal of pulse oximeter, 
transient loss of signals 
and sensor repositioning) 
of using equipment pulse 
oximetry equipment which 
would have confounded 
results
Antiepileptic drug withdrawal 
may have been performed 
during recordings to promote 
occurrence of seizures (?may 
have confounded results as 
not an organic seizure?)
Unclear % O2 given to each 
patient
Oxygen mask or nasal cannulae 
delivery given to each 
patient meaning different 
oxygen deliveries
Different lobes of epileptic 
seizures may confound 
results as certain lobes may 
induce more debilitating 
seizures which worsen SpO2 
evolution
Limited sample size
Nasal airflow and abdominal 
respiratory excursions 
not recorded limiting 
interpretation of origins of 
respiratory apnoea
Sackett's score = 2b
Mean duration of postictal 
hypoxaemia significantly reduced 
with early O2 administration
SpO2 nadir significantly less severe 
with early O2 administration
Delay between end of seizure and 
SpO2 nadir significantly reduced 
with early O2 administration
Rate of transient loss of SpO2 
signal and sensor disconnection 
were associated with type of 
oximetry sensor (lower rates with 
disposable flexiform sensors than 
finger clip sensor or reusable soft 
sensor
Future research must identify the 
best type of pulse oximetry to use 
in GCS analysis of hypoxaemia
Localization of epileptogenic zone 
could be done in 71 patients only
Must be determined whether or not 
the therapeutic effect of oxygen 
administration might be increased 
through optimization of oxygen 
delivery protocol
Only specific seizure types (focal with 
bilateral tonic– clonic evolution) 
included in this study so scope in 
future studies to examine other 
epilepsy types
Question remains “Is O2 therapy 
efficacy altered by mechanism 
of hypoxaemia (different when 
triggered by central apnoea or 
obstructive apnoea)
Commentary on these articles 
suggests that providing the 
patient a suction machine 
and education on proper GCS 
intervention may serve better 
than O2 delivery, but this would 
need to be given further research 
(Kotagel p., 2019)
(Continues)
6  |    SMITH et al.
Paper details Participant profile Epilepsy and seizure profile Oxygen therapy details Findings Bias and limitations Sackett's score and comments
Title:















Total number of 
participants (n = 
109)














Type of Seizures Observed:
21.3% primary GCS
78.6% partial- onset seizures with secondary 
GCS
(GCS, generalized convulsive seizures)
Raw Data Monitored During Seizures:
PGES presence and duration of the 
following: PGES, ESD, TCP, TP and CP.
Method of seizure recording:
Video- EEG recordings using 26 channels
Diagnosis of Epilepsy:
Unknown
Patients split into two groups, those that received peri- 
ictal intervention and those that did not
Separate analysis comparing patients that did and did not 
received oxygen administration
Oxygen and other ictal interventions given between ictal 
EEG onset and termination (usually preceding onset 
of PGES)
Improvement Measures:
Analysis of effect of administration of oxygen on entire seizure duration (EDS), 
tonic- clonic phase duration (TCP), tonic phase duration (TP), clonic phase 
duration (CP) and PGES duration (PGES). All variables measured in seconds, 
standard deviation shown to the right of the result in brackets
Relevant outcomes:
GCS With oxygen administered (n = 29):
ESD— 125.4 s (64.8)
TCP— 70.1 s (20.5)
TP— 27.8 s (20.1)
CP— 42.3 s (19.8)
PGES— 36.2 s (15.6)
GCS Without oxygen administered (n = 73):
ESD— 115.7 s (94.6)
TCP— 61.5 s (24.3)
TP— 17.4 s (14.4)
CP— 44.2 s (23.1)
PGES— 44.1 s (20.3)
No statistically significant results existed when comparing seizure- related 
variables between groups.
Other outcomes:
TP in GCS without PGES was 10.4 s shorter than GCS with PGES, this was 
statistically significant (p = .00086)
PGES duration was 15.5 s shorter in the group receiving peri- ictal intervention 
of any kind compared with the group receiving no peri- ictal intervention; 
this was statistically significant (p = .003)
Peri- ictal pulse oximetry only 
performed at discretion 
of nursing staff and not 
consistently measured
Formal respiratory monitoring 
not performed
The method of oxygen therapy 
delivered was not specified
Ictal oxygen was administered 
in 29 GCS, of which 93% 
received other interventions 
such as oral suction or body 
repositioning
Effect of oxygen therapy is 
confounded by effect of 
other interventions
Small number of participants 
receiving oxygen therapy 
meaning lack of statistical 
power
Demographics poorly defined, 
no mention of details of 
epilepsy diagnosis and what 
drugs patients were taking
Heterogeneous population 
studied confounding results
Peri- ictal interventions may have 
introduced artefact on the 
EEG from which seizure- 
related variables were 
derived confounding
Sackett's score =2b
There may have been reduction 
or discontinuance of epileptic 
medication to facilitate recording 
of habitual seizures
EEG recordings excluded if 
significantly obscured by muscle 
and electrode artefacts
Peri- ictal interventions (oxygen 
administration, oral suction and 
body repositioning) performed 
at discretion of nursing staff 
meaning bias of who received 
oxygen therapy was introduced
Title:













Total number of 
participants (n 
= 69)

























Type of Seizures Observed:
GCS
PGES present:
GCS type 1— (n = 33)
GCS type 2— (n = 4)
GCS type 3— (n = 10)
PGES absent:
GCS type 1— (n = 18)
GCS type 2— (n = 23)
GCS type 3— (n = 11)
Raw Data Monitored During Seizures:
Duration of tonic phase, duration of tonic- 
clonic phase, total seizure duration
Method of seizure recording:
Long- term scalp EEG recordings
Diagnosis of Epilepsy:
International League Against Epilepsy 
Classification
Patients split into two groups, those that experiences 
PGES and those that did not
PGES defined as immediate postictal (within 30 s 
following seizure termination), generalized and severe 
attenuation of scalp EEG activity no higher than 10 
microvolts in amplitude during greater than or equal 
to 10 s excluding artefact due to muscle, movements, 
electrodes and respiration.
Early O2 administration defined as patient with oxygen 
mask during the seizure or within the first 5 s after 
seizure termination
Improvement Measures:
Number and percentage of patients receiving early oxygen administration. 
Duration of tonic phase, duration of tonic- clonic phase and total seizure 
duration all measured in seconds. Prone positioning at end of seizure. 
If early intervention was given (apart from O2 administration). State of 
wakefulness.
Relevant Outcomes:
Oxygen administered early in 45 patients (45%)
PGES present:
Early O2 Administration (n = 10)
Late O2 Administration (n = 37)
PGES absent:
Early O2 Administration (n = 35)
Late O2 Administration (n = 17)
PGES presence was associated with lack of early oxygen administration in 
univariate and multivariate analysis (p < .001)
Other Outcomes:
Occurrence of PGES was significantly associated with longer duration of tonic 
phase and type of GCS (p < .001)
Details of oxygen therapy 
administered not discussed
Oxygen saturation and other 
respiratory monitoring data 
was purposefully discarded 
in this study
Limited sample size
Heterogeneity among epilepsy 
type in population
Administration of O2 done 
alongside interventions such 
as body positioning and 
electrode replacement may 
have confounded the results
Sackett's score = 2b
PGES was strongly prevented by early 
oxygen administration
TA B L E  1  (Continued)
(Continues)
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duration (CP) and PGES duration (PGES). All variables measured in seconds, 
standard deviation shown to the right of the result in brackets
Relevant outcomes:
GCS With oxygen administered (n = 29):
ESD— 125.4 s (64.8)
TCP— 70.1 s (20.5)
TP— 27.8 s (20.1)
CP— 42.3 s (19.8)
PGES— 36.2 s (15.6)
GCS Without oxygen administered (n = 73):
ESD— 115.7 s (94.6)
TCP— 61.5 s (24.3)
TP— 17.4 s (14.4)
CP— 44.2 s (23.1)
PGES— 44.1 s (20.3)
No statistically significant results existed when comparing seizure- related 
variables between groups.
Other outcomes:
TP in GCS without PGES was 10.4 s shorter than GCS with PGES, this was 
statistically significant (p = .00086)
PGES duration was 15.5 s shorter in the group receiving peri- ictal intervention 
of any kind compared with the group receiving no peri- ictal intervention; 
this was statistically significant (p = .003)
Peri- ictal pulse oximetry only 
performed at discretion 
of nursing staff and not 
consistently measured
Formal respiratory monitoring 
not performed
The method of oxygen therapy 
delivered was not specified
Ictal oxygen was administered 
in 29 GCS, of which 93% 
received other interventions 
such as oral suction or body 
repositioning
Effect of oxygen therapy is 
confounded by effect of 
other interventions
Small number of participants 
receiving oxygen therapy 
meaning lack of statistical 
power
Demographics poorly defined, 
no mention of details of 
epilepsy diagnosis and what 
drugs patients were taking
Heterogeneous population 
studied confounding results
Peri- ictal interventions may have 
introduced artefact on the 
EEG from which seizure- 
related variables were 
derived confounding
Sackett's score =2b
There may have been reduction 
or discontinuance of epileptic 
medication to facilitate recording 
of habitual seizures
EEG recordings excluded if 
significantly obscured by muscle 
and electrode artefacts
Peri- ictal interventions (oxygen 
administration, oral suction and 
body repositioning) performed 
at discretion of nursing staff 
meaning bias of who received 
oxygen therapy was introduced
Title:













Total number of 
participants (n 
= 69)

























Type of Seizures Observed:
GCS
PGES present:
GCS type 1— (n = 33)
GCS type 2— (n = 4)
GCS type 3— (n = 10)
PGES absent:
GCS type 1— (n = 18)
GCS type 2— (n = 23)
GCS type 3— (n = 11)
Raw Data Monitored During Seizures:
Duration of tonic phase, duration of tonic- 
clonic phase, total seizure duration
Method of seizure recording:
Long- term scalp EEG recordings
Diagnosis of Epilepsy:
International League Against Epilepsy 
Classification
Patients split into two groups, those that experiences 
PGES and those that did not
PGES defined as immediate postictal (within 30 s 
following seizure termination), generalized and severe 
attenuation of scalp EEG activity no higher than 10 
microvolts in amplitude during greater than or equal 
to 10 s excluding artefact due to muscle, movements, 
electrodes and respiration.
Early O2 administration defined as patient with oxygen 
mask during the seizure or within the first 5 s after 
seizure termination
Improvement Measures:
Number and percentage of patients receiving early oxygen administration. 
Duration of tonic phase, duration of tonic- clonic phase and total seizure 
duration all measured in seconds. Prone positioning at end of seizure. 
If early intervention was given (apart from O2 administration). State of 
wakefulness.
Relevant Outcomes:
Oxygen administered early in 45 patients (45%)
PGES present:
Early O2 Administration (n = 10)
Late O2 Administration (n = 37)
PGES absent:
Early O2 Administration (n = 35)
Late O2 Administration (n = 17)
PGES presence was associated with lack of early oxygen administration in 
univariate and multivariate analysis (p < .001)
Other Outcomes:
Occurrence of PGES was significantly associated with longer duration of tonic 
phase and type of GCS (p < .001)
Details of oxygen therapy 
administered not discussed
Oxygen saturation and other 
respiratory monitoring data 
was purposefully discarded 
in this study
Limited sample size
Heterogeneity among epilepsy 
type in population
Administration of O2 done 
alongside interventions such 
as body positioning and 
electrode replacement may 
have confounded the results
Sackett's score = 2b
PGES was strongly prevented by early 
oxygen administration
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= 39)














Type of Seizures Observed:
Secondarily generalized convulsions
Right temporal onset (n = 42)
Left temporal onset (n = 32)
Near simultaneous bitemporal onset (n = 3)
Frontal onset (n = 15)
Could not be determined (n = 12)
Raw Data Monitored During Seizures:
Seizure duration, onset of localization, 
duration of convulsive component of 
seizure, pre- ictal baseline SaO2 and 
ETCO2, time of onset of hypoxaemia 
(SaO2 drop below 90%), SaO2 nadir, 
peak ETCO2 during ictal/postictal 
phases, duration of PGES




Data analysed in consecutive patients
Patients receiving nursing interventions (INT) compared 
to those that did not receive nursing interventions 
(NOINT)
Two groups compared against duration of PGES and 
hypoxaemia
Analysis to see impact of interventions given prior to 
onset of hypoxaemia compared to after hypoxaemia 
onset
Improvement Measures:
Duration of hypoxaemia, total seizure duration, SaO2 desaturation nadir, 
duration of postictal immobility, ETCO2, PGES duration.
Relevant Outcomes:
Number of seizures in INT group (n = 84)
Number of seizures in NOINT group (n = 21)
INT Breakdown of Interventions:
Oxygen administered (n = 41)
Recumbent lateral positioning (47)
Suctioning administered (n = 65)
Impact of interventions on duration of hypoxaemia
No significant difference in the slopes of the three interventions including 
administration of oxygen versus duration of hypoxaemia (p = .5316)
Duration of PGES and Seizure Onset
Linear regression indicated significant positive linear relationship between time 
of first intervention relative to seizure onset and duration of PGES (p = 
.0012)
Mean duration of hypoxaemia with any intervention prior to hypoxaemia onset
Mean 53.1 s ± SD 45.1 s (median 44, range 8– 158)
Mean duration of hypoxaemia with any intervention after hypoxaemia onset
Mean 132.4 s ± SD 134.9 s (median 103, range 38– 712)
Significant difference in mean duration of hypoxaemia between INT and NOINT 
(p < .0001)
Duration of hypoxaemia in NOINT
Mean 48.9 ± SD 40.9 s (median 37, range 10– 188)
Duration of hypoxaemia in INT
Mean 110.9 ± SD 93.9 s (median 99, range 8– 712)
The time of onset of hypoxaemia from seizure onset was not significantly 
different between the two groups (p = .3351).I
Interval to onset of hypoxaemia from seizure onset in NOINT
Mean 101.6 ± SD 78.3 s (median 77, range 32– 317)
Interval to onset of hypoxaemia from seizure onset in INT
Mean 81.5 ± SD 59.7 s (median 63, range 12– 404).
Mean O2 desaturation nadir in NOINT compared to INT was statistically 
significant (p = .0086)
O2 Desaturation Nadir in NOINT
Mean 79.8% ± SD 7.7% (median 83, range 61– 91)
O2 Desaturation Nadir in INT
Mean 72.8% ± SD 11.4% (median 75, range 42– 93)
The difference in peak ictal/postictal ETCO2 between the two groups was 
significant (p = .0359)
Peak ictal/postictal ETCO2 in NOINT
Mean 50.3 ± SD 7.1 mmHg (median 51, range 40– 61)
Peak ictal/postictal ETCO2 in INT
Mean 58.6 ± SD 13.1 mm Hg (median 59.5, range 38– 94).
Intervention of any kind and in any combination given prior to onset of 
hypoxaemia resulted in shorter duration of hypoxaemia when compared to 
interventions occurring after hypoxaemia onset (p = .0014)
SaO2 nadir not significantly different for interventions before and following 
onset of hypoxaemia
Other Outcomes:
No significant difference in mean duration of seizure (p = .3514) or mean 
duration of convulsive component (p = .3971) between INT and NOINT
Duration of postictal immobility was significantly related to lower O2 nadir (p 
= .003)
Duration of PGES (occurred in INT group only)
Mean 41.6 ± SD 25.3 s (median 36, range 2– 117)
Multiple interventions given by 
nurses meaning pure effect 
of oxygen administration 
cannot be determined
Retrospective nature of study is 
a limitation
Variance in effectiveness of 
care given by nurses due to 
differing experience levels
Sackett's score = 2b
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No significant difference in the slopes of the three interventions including 
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Duration of PGES and Seizure Onset
Linear regression indicated significant positive linear relationship between time 
of first intervention relative to seizure onset and duration of PGES (p = 
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Mean 53.1 s ± SD 45.1 s (median 44, range 8– 158)
Mean duration of hypoxaemia with any intervention after hypoxaemia onset
Mean 132.4 s ± SD 134.9 s (median 103, range 38– 712)
Significant difference in mean duration of hypoxaemia between INT and NOINT 
(p < .0001)
Duration of hypoxaemia in NOINT
Mean 48.9 ± SD 40.9 s (median 37, range 10– 188)
Duration of hypoxaemia in INT
Mean 110.9 ± SD 93.9 s (median 99, range 8– 712)
The time of onset of hypoxaemia from seizure onset was not significantly 
different between the two groups (p = .3351).I
Interval to onset of hypoxaemia from seizure onset in NOINT
Mean 101.6 ± SD 78.3 s (median 77, range 32– 317)
Interval to onset of hypoxaemia from seizure onset in INT
Mean 81.5 ± SD 59.7 s (median 63, range 12– 404).
Mean O2 desaturation nadir in NOINT compared to INT was statistically 
significant (p = .0086)
O2 Desaturation Nadir in NOINT
Mean 79.8% ± SD 7.7% (median 83, range 61– 91)
O2 Desaturation Nadir in INT
Mean 72.8% ± SD 11.4% (median 75, range 42– 93)
The difference in peak ictal/postictal ETCO2 between the two groups was 
significant (p = .0359)
Peak ictal/postictal ETCO2 in NOINT
Mean 50.3 ± SD 7.1 mmHg (median 51, range 40– 61)
Peak ictal/postictal ETCO2 in INT
Mean 58.6 ± SD 13.1 mm Hg (median 59.5, range 38– 94).
Intervention of any kind and in any combination given prior to onset of 
hypoxaemia resulted in shorter duration of hypoxaemia when compared to 
interventions occurring after hypoxaemia onset (p = .0014)
SaO2 nadir not significantly different for interventions before and following 
onset of hypoxaemia
Other Outcomes:
No significant difference in mean duration of seizure (p = .3514) or mean 
duration of convulsive component (p = .3971) between INT and NOINT
Duration of postictal immobility was significantly related to lower O2 nadir (p 
= .003)
Duration of PGES (occurred in INT group only)
Mean 41.6 ± SD 25.3 s (median 36, range 2– 117)
Multiple interventions given by 
nurses meaning pure effect 
of oxygen administration 
cannot be determined
Retrospective nature of study is 
a limitation
Variance in effectiveness of 
care given by nurses due to 
differing experience levels
Sackett's score = 2b
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(D2, B6SAS and 
Primed- B6) were 
used.
Each strain had three 
test groups.
Total number of mice 
used in study (n 
= 279)
Age:
D2 and primed- B6 
mice tested at age 
21 ± 1 day.
B6SAS mice tested at 
age 26 ± 2 days
Sex:
Mixture of male and 
female mice used. 
No data available 
on specific 





All mice tested at ages stated previously.
Duration:
Unknown.
Type of Seizures Observed:
Audiogenic seizures manifest in three 
phases: wild running, clonic and tonic 
seizures.
Raw Data Monitored During Seizures:
Numeric scores based on severity of seizure 
observed.




All three strains of mice were divided into three groups, 
and two more treatment groups were created out of 
mouse survivors in group two.
Treatment group one were mice placed in a normal air 
chamber for their auditory- induced seizure.
Treatment group two were placed in a chamber of 
medically pure oxygen for their seizure.
Treatment group 3, included mice that survived from 
group 2 and were tested 24 h later in an oxygen 
chamber.
Treatment group 4 included mice that survived from 
group 2 and were tested 24 h later in an air chamber.
Treatment group 5 included mice that were tested in an 
air chamber 1 min after being exposed to oxygen for 
2 min prior
Improvement Measures:
The effect of oxygenation on sudden fatal audiogenic seizures in three mouse 
strains.
Outcomes:
Oxygenation completely prevented fatal seizures in all three mouse strains 
(treatment groups 2). This is in comparison with fatal seizures that occurred 
in 100%, 100% and 58% of the air- treated D2, B6SAS and primed- B6 mice 
(treatment groups 1), respectively.
p value <.01
Oxygenation had no effect on incidence or severity of AGS.
Other Outcomes:
To assess long- term protective effects of oxygenation, some of the mice that 
survived in treatment group 2, from each mice strain, were tested 24 h later 
in either air (treatment groups 3) or oxygen (treatment groups 4) chambers. 
Majority of mice in treatment group 3 died; however, no mice in group 4 
died. Again, no difference was found in AGS severity in either group.
To assess short- term protective effects of oxygenation, mice from each strain 
were exposed to 2 min of oxygen 1 min prior to being tested (treatment 
groups 5). The majority of mice in this group died suddenly.
Sudden ictal death in humans 
may share some common 
mechanisms to sudden fatal 
AGSs in mice. However, it 
is not an exact model of 
mechanism or physiology
Varying mice strains confound 
results due to variability in 
genetic predisposition to 
AGS and potential influence 
on oxygen efficacy
No author's comments on 
potential limitations or 
introduction of bias
Sackett's score = 2b
Oxygenation at time of AGS 
completely prevented sudden 
fatal AGSs in mice.
Oxygenation had no protective effect 
on the incidence or severity of 
AGS
Testing of treatment groups three and 
four suggested that oxygenation 
had no long- term protective 
effect in preventing fatal AGSs.
Testing of treatment group five 
suggested that oxygenation had 
no short- term effect of preventing 
fatal AGSs as mice exposed to 
oxygen prior to AGS mostly died.
Oxygen is most effective at the time 
of seizure
Mechanisms of human sudden 
unexpected death in epilepsy 
(SUDEP) may be related to 
anoxia— which could be similar to 
the mechanisms in sudden fatal 
AGSs in mice.
SUDEP usually occurs in sleep, and so 
patients at risk could wear oxygen 
masks to mitigate this risk
Further tests are needed to test the 
possibility of therapeutic hypoxic 
conditioning with the aim of 
increasing hypoxic tolerance.
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Treatment group 5 included mice that were tested in an 
air chamber 1 min after being exposed to oxygen for 
2 min prior
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strains.
Outcomes:
Oxygenation completely prevented fatal seizures in all three mouse strains 
(treatment groups 2). This is in comparison with fatal seizures that occurred 
in 100%, 100% and 58% of the air- treated D2, B6SAS and primed- B6 mice 
(treatment groups 1), respectively.
p value <.01
Oxygenation had no effect on incidence or severity of AGS.
Other Outcomes:
To assess long- term protective effects of oxygenation, some of the mice that 
survived in treatment group 2, from each mice strain, were tested 24 h later 
in either air (treatment groups 3) or oxygen (treatment groups 4) chambers. 
Majority of mice in treatment group 3 died; however, no mice in group 4 
died. Again, no difference was found in AGS severity in either group.
To assess short- term protective effects of oxygenation, mice from each strain 
were exposed to 2 min of oxygen 1 min prior to being tested (treatment 
groups 5). The majority of mice in this group died suddenly.
Sudden ictal death in humans 
may share some common 
mechanisms to sudden fatal 
AGSs in mice. However, it 
is not an exact model of 
mechanism or physiology
Varying mice strains confound 
results due to variability in 
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AGS and potential influence 
on oxygen efficacy
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Testing of treatment groups three and 
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Oxygen is most effective at the time 
of seizure
Mechanisms of human sudden 
unexpected death in epilepsy 
(SUDEP) may be related to 
anoxia— which could be similar to 
the mechanisms in sudden fatal 
AGSs in mice.
SUDEP usually occurs in sleep, and so 
patients at risk could wear oxygen 
masks to mitigate this risk
Further tests are needed to test the 
possibility of therapeutic hypoxic 
conditioning with the aim of 
increasing hypoxic tolerance.
 13. Randomised study of antiepileptic drug withdrawal in patients in re-
mission. Medical Research Council Antiepileptic Drug Withdrawal 
Study Group. Lancet. 1991;337:1175- 1180.
SUPPORTING INFORMATION
Additional supporting information may be found online in the 
Supporting Information section.
How to cite this article: Smith AN, Abraham J, Shankar R. 
Oxygen for seizures, more questions than answers: A scoping 
review. Acta Neurol Scand. 2021;00:1– 11. https://doi.
org/10.1111/ane.13508
APPENDIX 1
LITER ATURE SE ARCH TERMS
Epilepsy Terms:
exp "SEIZURE, EPILEPSY AND CONVULSION"/
(convuls* OR seizure* OR epilep*).
Hypoxia Terms.
(hypoxia OR hypoxic).ti,ab.
(HYPOXIA OR BRAIN HYPOXIA OR HYPOXIC LUNG 
VASOCONSTRICTION OR INTERMITTENT HYPOXIA).
(anoxia OR anoxic OR anoxemia OR anoxemic).
(Hypoventilation).
(hyperventilation).
(hypoxemia OR hypoxemic OR hypoxaemia OR hypoxaemic).
Oxygen Therapy Terms.
exp "OXYGEN THERAPY"/
exp "OXYGEN DELIVERY DEVICE"/
(oxygenation OR Hyperbaric oxygen).
((treatment OR management OR administration OR therapy) 
ADJ2 oxygen).
(supplementary oxygen).
